Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

Olive Hospital has achieved a major breakthrough in the field of Interventional Cardiology by successfully completing its ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Aortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing ...

Memorial Health System’s Department of Cardiology marked a major milestone in heart-healthy care, celebrating its 100th ...

Roger Black has spoken about the heart surgery he underwent in January and the fear he felt before going under the knife ...

Findings from the first 500 patients treated with the Trilogy system met noninferiority for both safety and efficacy.

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and ...

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...